Cargando…
Endocrine Toxicity and Outcomes in Patients With Metastatic Malignancies Treated With Immune Checkpoint Inhibitors
CONTEXT: Immune checkpoint inhibitors (ICIs) have gained a revolutionary role in management of many advanced malignancies. However, immune-related endocrine events (irEEs), have been associated with their use. irEEs have nonspecific clinical presentations and variable timelines, making their early d...
Autores principales: | Al Ashi, Suleiman I, Thapa, Bicky, Flores, Monica, Ahmed, Ramsha, Rahim, Shab E Gul, Amir, Maryam, Alomari, Mohammad, Chadalavada, Pravallika, Morrison, Shannon L, Bena, James F, Hercbergs, Aleck, Lashin, Ossama, Daw, Hamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237848/ https://www.ncbi.nlm.nih.gov/pubmed/34195529 http://dx.doi.org/10.1210/jendso/bvab100 |
Ejemplares similares
-
Gastrointestinal Toxicities of Immune Checkpoint Inhibitors Are Associated With Enhanced Tumor Responsiveness and Improved Survival
por: Alomari, Mohammad, et al.
Publicado: (2022) -
Prevalence and Predictors of Gastrointestinal Dysmotility in Patients with Hypermobile Ehlers-Danlos Syndrome: A Tertiary Care Center Experience
por: Alomari, Mohammad, et al.
Publicado: (2020) -
Hemophagocytic Lymphohistiocytosis Associated with Natural T-cell Leukemia
por: Ricaurte, Frank R, et al.
Publicado: (2019) -
Clinical Implications and Impact of Discovery of the Thyroid Hormone Receptor on Integrin αvβ3–A Review
por: Hercbergs, Aleck
Publicado: (2019) -
Colony-stimulating Factor 3 Receptor Mutated Chronic Neutrophilic Leukemia: A Rare Case Report
por: Thapa, Bicky, et al.
Publicado: (2018)